resources

Aarti Drugs Ltd.

NSE: AARTIDRUGS

BSE: 524348

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

421.50-1.5 (-0.35%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Aarti Drugs Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Quarterly Results	—	—	—	—	—	Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	9Jun 31Aug 15Nov	14Feb 16May 3Aug 31Oct	3Feb 7May 28Jul 27Oct	1Feb 10May 5Aug 25Oct 2Nov	4Feb 25Jul 14Nov	10Feb 23May 7Aug
Presentations	—	—	—	—	—	—	—	—	28Jan 17May 28Jul 27Oct	31Jan 9May 7Jun 27Jul 4Aug 20Oct	27Jan 2May 21Jul 26Sept 19Oct	24Jan 4May 26Jul 20Sept 24Oct	29Jan 6May 19Jul 24Sept 7Nov	3Feb 16May 1Aug

Corporate Announcements and Regulatory Filings

Aarti Drugs Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

Newspaper Publication3 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Business Responsibility and Sustainability Reporting (BRSR)2 Sept 2026
Business Responsibility and Sustainability Reporting (BRSR)
Please find attached BRSR for FY 2025-26
AGM2 Sept 2026
Notice Of 41St Annual General Meeting Of The Company
Please find attached Notice of 41st Annual General Meeting of the Company
Reg. 34 (1) Annual Report2 Sept 2026
Reg. 34 (1) Annual Report.
Please find attached Annual Report for FY 2025-26
Newspaper Publication1 Sept 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication
Outcome of Board Meeting27 Aug 2026
Board Meeting Outcome for Approval Of Aarti Drugs Limited Performance Stock Option Plan 2026
approval of Aarti Drugs Limited Performance Stock Option Plan 2026
Closure of Trading Window24 Aug 2026
Closure of Trading Window
Closure of Trading Window
Board Meeting24 Aug 2026
Board Meeting Intimation for ''Aarti Drugs Limited - Performance Stock Option Plan 2026',
Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/08/2026 ,inter alia, to consider and approve 'Aarti Drugs Limited - Performance ....
Analyst / Investor Meet14 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst/ Institutional Meet
General10 Aug 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Disclosure under Regulation 30 of SEBI Listing Regulations
Analyst / Investor Meet4 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analyst /Institutional Investors Meeting
Analyst / Investor Meet3 Aug 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Q1FY27 Earning Conference call recording
Newspaper Publication3 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Publication on Financial results
Press Release / Media Release1 Aug 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Q1FY27 Business and Financial Performance
General1 Aug 2026
Revocation Of Closure Order By GPCB Related To Plant Located At Sayakha
Revocation of closure order by GPCB related to plant located at Sayakha
Press Release / Media Release31 Jul 2026
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Aarti Drugs Limited Announces Leadership Transition to Strengthen Governance and Ensure Long-term Strategic Growth
Change in Directorate31 Jul 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
Change in Directorate
Outcome of Board Meeting31 Jul 2026
Board Meeting Outcome for Financial Results For The Quarter Ended June 30, 2026
Financial Results for the quarter ended June 30, 2026
Analyst / Investor Meet29 Jul 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Q1 Earning Conference Call
Board Meeting24 Jul 2026
Board Meeting Intimation for Considering The Financial Results For The Quarter Ended June 30, 2026
Aarti Drugs Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Financial results for the quarter ....

Frequently Asked Questions

Where can I download the annual report of Aarti Drugs Ltd.?

Annual reports of Aarti Drugs Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Aarti Drugs Ltd.?

Quarterly earnings results and presentations of Aarti Drugs Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Aarti Drugs Ltd. publish earnings call transcripts?

Earnings call transcripts of Aarti Drugs Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Aarti Drugs Ltd.?

Investor presentations and annual day presentations of Aarti Drugs Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Aarti Drugs Ltd.?

Corporate announcements and regulatory filings of Aarti Drugs Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Aarti Drugs Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Aarti Drugs Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Aarti Drugs Ltd.?

The ISIN (International Securities Identification Number) of Aarti Drugs Ltd. is INE767A01016. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Aarti Drugs Ltd. listed?

Aarti Drugs Ltd. is listed on NSE and BSE. The NSE symbol is AARTIDRUGS and the BSE code is -.

Where can I find the shareholding pattern of Aarti Drugs Ltd.?

The quarterly shareholding pattern of Aarti Drugs Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Aarti Drugs Ltd. on Sharpely?

Share price data for Aarti Drugs Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.